Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.

Adults taking a high antihistamine dose vs. placebo before endurance exercise training sessions had less improvement in peak ...